- Home
- CWD vs SBFM Comparison
CWD vs SBFM Comparison
Compare CWD & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWD | SBFM |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 4.3M |
| IPO Year | 2022 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CWD | SBFM |
|---|---|---|
| Price | $0.44 | $0.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.1M | ★ 9.9M |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $20,097,000.00 | ★ $36,305,891.00 |
| Revenue This Year | N/A | $1.23 |
| Revenue Next Year | $19.16 | $22.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $0.43 | $0.21 |
| 52 Week High | $3.75 | $22.00 |
Technical Indicators
Market Signals| Indicator | CWD | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 36.69 | 26.29 |
| Support Level | N/A | N/A |
| Resistance Level | $0.60 | $1.26 |
| Average True Range (ATR) | 0.05 | 0.14 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 2.08 | 2.45 |
Price Performance
Historical ComparisonAbout CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm investing across real and digital assets. It sponsors and manages private real estate investment funds and maintains a digital asset treasury approach focused on blockchain infrastructure assets. The company's activities are supported by transaction and advisory services, including development and construction management, acquisition and disposition services, brokerage, and fund formation services. The company operates through one reportable segment. It generates the majority of its revenue in the form of asset management fee revenues and performance allocations.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.